| P2093 | author name string | Carruba MO | |
| | Nisoli E | |
| P2860 | cites work | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
| | Positional cloning of the mouse obese gene and its human homologue | Q22251285 |
| | Identification of receptors for neuromedin U and its role in feeding | Q22254611 |
| | Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein | Q24314579 |
| | Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity | Q24635198 |
| | Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor | Q24674586 |
| | The ciliary neurotrophic factor and its receptor, CNTFR alpha | Q28144474 |
| | Leptin-regulated endocannabinoids are involved in maintaining food intake | Q28211969 |
| | The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization | Q28268966 |
| | Hypothalamic CART is a new anorectic peptide regulated by leptin | Q28271095 |
| | A frameshift mutation in human MC4R is associated with a dominant form of obesity | Q28285286 |
| | Role of melanocortinergic neurons in feeding and the agouti obesity syndrome | Q28300979 |
| | Targeted disruption of the melanocortin-4 receptor results in obesity in mice | Q28302831 |
| | Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain | Q28307200 |
| | Central melanocortin receptors regulate insulin action | Q28360753 |
| | Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland | Q28371734 |
| | Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice | Q28505938 |
| | Intracellular signalling. Key enzyme in leptin-induced anorexia | Q28573472 |
| | Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor | Q28594995 |
| | Central nervous system control of food intake | Q29547439 |
| | Weight-reducing effects of the plasma protein encoded by the obese gene | Q29617934 |
| | Congenital leptin deficiency is associated with severe early-onset obesity in humans | Q29618702 |
| | Ghrelin induces adiposity in rodents | Q29619226 |
| | Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus | Q29619635 |
| | A role for ghrelin in the central regulation of feeding | Q29620403 |
| | Effect of sibutramine on weight maintenance after weight loss: a randomised trial | Q33128832 |
| | The Central Melanocortin System and Energy Homeostasis | Q33687989 |
| | Pharmacologic therapy for type 2 diabetes mellitus | Q33716414 |
| | Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress | Q33829104 |
| | Orlistat, a new lipase inhibitor for the management of obesity | Q33871474 |
| | Effects of recombinant leptin therapy in a child with congenital leptin deficiency. | Q33874084 |
| | Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides | Q33896557 |
| | Towards cannabinoid drugs--revisited. | Q33906007 |
| | Afferent signals regulating food intake | Q34039602 |
| | Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist | Q34138869 |
| | Gut hormone PYY(3-36) physiologically inhibits food intake | Q34143493 |
| | Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance | Q34386993 |
| | Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice | Q34423145 |
| | BDNF regulates eating behavior and locomotor activity in mice | Q34667950 |
| | Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years | Q34722458 |
| | An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action | Q34742716 |
| | Role of the Y5 neuropeptide Y receptor in feeding and obesity | Q38336720 |
| | A role for melanin-concentrating hormone in the central regulation of feeding behaviour | Q38360259 |
| | Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators | Q40750338 |
| | Medical hazards of obesity | Q40841355 |
| | Pharmaceutical treatment of obesity. | Q41654163 |
| | Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade | Q41747645 |
| | Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice | Q41751695 |
| | Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells. | Q42822243 |
| | Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling | Q42991205 |
| | Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet | Q43743252 |
| | Intracerebroventricular CART peptide reduces food intake and alters motor behavior at a hindbrain site | Q43797582 |
| | Interleukin-6-deficient mice develop mature-onset obesity | Q43851625 |
| | Central administration of oleic acid inhibits glucose production and food intake | Q43867506 |
| | Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity | Q47194015 |
| | Role of brain insulin receptor in control of body weight and reproduction | Q47229086 |
| | Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors | Q47235692 |
| | Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial | Q47254016 |
| | Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. | Q47256568 |
| | Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine | Q47265863 |
| | Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study | Q47693449 |
| | Signals that regulate food intake and energy homeostasis | Q48035240 |
| | Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms. | Q48116728 |
| | Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion | Q48203453 |
| | Injection of anti-neuropeptide Y γ-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats | Q48345553 |
| | Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus | Q48589066 |
| | Appetite-suppressing effects of urocortin, a CRF-related neuropeptide | Q48918115 |
| | Leptin(116-130) stimulates prolactin and luteinizing hormone secretion in fasted adult male rats. | Q51560513 |
| | Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. | Q52522147 |
| | Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. | Q52892360 |
| | Partial leptin deficiency and human adiposity. | Q55035506 |
| | A leptin missense mutation associated with hypogonadism and morbid obesity. | Q55067416 |
| | Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice | Q58449888 |
| | Guidelines for the approval and use of drugs to treat obesity. A position paper of The North American Association for the Study of Obesity | Q70786278 |
| | Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man | Q71748410 |
| | Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity | Q71899836 |
| | Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression | Q72554895 |
| | Orlistat in the long-term treatment of obesity in primary care settings | Q73490701 |
| | Obesity market overview | Q74467938 |
| | Environmental contributions to the obesity epidemic | Q74594316 |
| | Obesity: how big a problem? | Q74675913 |
| | Obesity | Q77665702 |
| P433 | issue | 10 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 905-914 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
| P1476 | title | New pharmacological tools for obesity | |
| P478 | volume | 25 | |